Macrocyclics, Inc. 是一家定制螯合剂制造商，致力于开发新的螯合化学平台，这对于诊断和治疗医学的进步至关重要。

Macrocyclics 由 A. Dean Sherry 教授于 1995 年创立，这是他在开发金属离子的大环配体及其用作 MRI 造影剂方面的开创性研究的结果。 他的开创性工作激发了该领域许多研究人员的全球兴趣，并创造了对首先在雪利酒实验室制备的大环螯合剂的需求。 由于合成和纯化的挑战性，Sherry 教授经常收到同事的样品请求，最终超出了他的 UTD 研究实验室的管理能力。 结果是 1993 年“磁共振解决方案”的诞生，后来在 1995 年更名为 Macrocyclics。

Macrocyclics, Inc., a manufacturer of customized chelating agents, is dedicated to leading-edge development of new chelation chemistry platforms critical for advancement of diagnostic and therapeutic medicine.

Macrocyclics was founded in 1995 by Professor A. Dean Sherry as a result of his pioneering research in the development macrocyclic ligands for metal ions and their use as MRI contrast media. His ground breaking work stimulated worldwide interest by many researchers in the field and created a demand for macrocyclic chelating agents that were first prepared in the Sherry lab. Due to the challenging nature of the syntheses and purification, Professor Sherry would frequently receive requests for samples by his colleagues which eventually grew beyond the capacity of his UTD research lab to manage. The result was the birth of “Magnetic Resonance Solutions” in 1993 which was later renamed Macrocyclics in 1995.

常卖产品：

靶点科技（北京）有限公司是macrocyclics在中国的总代理。被官方授权在中国负责品牌宣传推广，产品售前咨询和售后服务等一切商业活动和行为。靶点科技有专业技术团队，竭力为广大中国客户提供全方位的产品和服务赋能支持。

Macrocyclics官网中文网站：筹备中……

Macrocyclics官网英文网站：www.macrocyclics.com